As published by ‘pressat’, Code Pharma, a Netherlands-based pharmaceutical company, is preparing to showcase groundbreaking findings on GAMMORA, a drug aimed at treating HIV, at two major conferences in late 2024. The first event, the HIV Drug Therapy 2024 Conference in Glasgow this November, will reveal early-stage clinical trial results, highlighting GAMMORA’s potential to transform HIV treatment. In December, the company will present at the HIV Persistence During Therapy Workshop in Miami, emphasizing the drug’s innovative approach to targeting HIV.
Menu